BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 26908947)

  • 1. Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217.
    Benn M; Watts GF; Tybjærg-Hansen A; Nordestgaard BG
    Eur Heart J; 2016 May; 37(17):1384-94. PubMed ID: 26908947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of Familial Hypercholesterolemia and High Low-Density Lipoprotein Cholesterol to Ischemic Stroke: Copenhagen General Population Study.
    Beheshti S; Madsen CM; Varbo A; Benn M; Nordestgaard BG
    Circulation; 2018 Aug; 138(6):578-589. PubMed ID: 29593013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study.
    Langsted A; Kamstrup PR; Benn M; Tybjærg-Hansen A; Nordestgaard BG
    Lancet Diabetes Endocrinol; 2016 Jul; 4(7):577-87. PubMed ID: 27185354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of clinical familial hypercholesterolaemia among patients with high cholesterol levels.
    Martinsen MH; Hedegaard BS; Klausen IC; Mortensen MB
    Dan Med J; 2019 Nov; 66(11):. PubMed ID: 31686647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The type of mutation in the low density lipoprotein receptor gene influences the cholesterol-lowering response of the HMG-CoA reductase inhibitor simvastatin in patients with heterozygous familial hypercholesterolaemia.
    Heath KE; Gudnason V; Humphries SE; Seed M
    Atherosclerosis; 1999 Mar; 143(1):41-54. PubMed ID: 10208479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DIAgnosis and Management Of familial hypercholesterolemia in a Nationwide Design (DIAMOND-FH): Prevalence in Switzerland, clinical characteristics and the diagnostic value of clinical scores.
    Miserez AR; Martin FJ; Spirk D
    Atherosclerosis; 2018 Oct; 277():282-288. PubMed ID: 30270060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of expanded genetic analysis in the diagnosis of familial hypercholesterolemia in patients with very early-onset coronary artery disease.
    Cao YX; Wu NQ; Sun D; Liu HH; Jin JL; Li S; Guo YL; Zhu CG; Gao Y; Dong QT; Liu G; Dong Q; Li JJ
    J Transl Med; 2018 Dec; 16(1):345. PubMed ID: 30526649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis in UK patients with a clinical diagnosis of familial hypercholesterolaemia: relationship with plasma lipid traits, heart disease risk and utility in relative tracing.
    Humphries SE; Cranston T; Allen M; Middleton-Price H; Fernandez MC; Senior V; Hawe E; Iversen A; Wray R; Crook MA; Wierzbicki AS
    J Mol Med (Berl); 2006 Mar; 84(3):203-14. PubMed ID: 16389549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Comparative Analysis of Phenotypic Predictors of Mutations in Familial Hypercholesterolemia.
    Chan DC; Pang J; Hooper AJ; Bell DA; Bates TR; Burnett JR; Watts GF
    J Clin Endocrinol Metab; 2018 Apr; 103(4):1704-1714. PubMed ID: 29408959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, clinical features and prognosis of familial hypercholesterolemia in Chinese Han patients with acute coronary syndrome after a coronary event: a retrospective observational study.
    Kou H; Wang H; Liu P; Wang X; Zhu W; Jiang W; Hu X; Deng J
    BMC Cardiovasc Disord; 2024 Mar; 24(1):144. PubMed ID: 38443803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of clinical diagnostic criteria for familial hypercholesterolemia genetic testing in Poland.
    Mickiewicz A; Chmara M; Futema M; Fijalkowski M; Chlebus K; Galaska R; Bandurski T; Pajkowski M; Zuk M; Wasag B; Limon J; Rynkiewicz A; Gruchala M
    Atherosclerosis; 2016 Jun; 249():52-8. PubMed ID: 27062410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features of familial hypercholesterolemia in Korea: Predictors of pathogenic mutations and coronary artery disease - A study supported by the Korean Society of Lipidology and Atherosclerosis.
    Shin DG; Han SM; Kim DI; Rhee MY; Lee BK; Ahn YK; Cho BR; Woo JT; Hur SH; Jeong JO; Jang Y; Lee JH; Lee SH
    Atherosclerosis; 2015 Nov; 243(1):53-8. PubMed ID: 26343872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How To Identify Familial Premature Myocardial Infarction: Comparing Approaches To Identify Familial Hypercholesterolemia.
    Beheshti S; Madsen CM; Varbo A; Nordestgaard BG
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2657-2667. PubMed ID: 30753598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of familial hypercholesterolemia in patients with premature myocardial infarction.
    Cui Y; Li S; Zhang F; Song J; Lee C; Wu M; Chen H
    Clin Cardiol; 2019 Mar; 42(3):385-390. PubMed ID: 30637778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterozygous familial hypercholesterolaemia in a pair of identical twins: a case report and updated review.
    Mohd Nor NS; Al-Khateeb AM; Chua YA; Mohd Kasim NA; Mohd Nawawi H
    BMC Pediatr; 2019 Apr; 19(1):106. PubMed ID: 30975109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of adjusting LDL-cholesterol for Lp(a)-cholesterol on the diagnosis of familial hypercholesterolaemia.
    Thayabaran D; Tsui APT; Ebmeier S; Cegla J; David A; Jones B
    J Clin Lipidol; 2023; 17(2):244-254. PubMed ID: 36870882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and management of familial hypercholesterolaemia in patients with acute coronary syndromes.
    Nanchen D; Gencer B; Auer R; Räber L; Stefanini GG; Klingenberg R; Schmied CM; Cornuz J; Muller O; Vogt P; Jüni P; Matter CM; Windecker S; Lüscher TF; Mach F; Rodondi N
    Eur Heart J; 2015 Sep; 36(36):2438-45. PubMed ID: 26142466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Lipoprotein(a) on the Diagnosis of Familial Hypercholesterolemia: Does It Make a Difference in the Clinic?
    Chan DC; Pang J; Hooper AJ; Bell DA; Burnett JR; Watts GF
    Clin Chem; 2019 Oct; 65(10):1258-1266. PubMed ID: 31307996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectrum of LDLR gene mutations, including a novel mutation causing familial hypercholesterolaemia, in North-western Greece.
    Diakou M; Miltiadous G; Xenophontos SL; Manoli P; Cariolou MA; Elisaf M
    Eur J Intern Med; 2011 Oct; 22(5):e55-9. PubMed ID: 21925044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.